Global and Region Antibody-drug Conjugate Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of Antibody-drug Conjugate market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Antibody-drug Conjugatemarket, defines the market attractiveness level of Antibody-drug Conjugate market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Antibody-drug Conjugate industry, describes the types of Antibody-drug Conjugate market, the applications of major players and the market size, and deeply analyzes the current situation of the global Antibody-drug Conjugate market and the development prospects and opportunities of Antibody-drug Conjugate industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Antibody-drug Conjugate market in Chapter 13.

    By Player:

    • Celldex Therapeutics

    • Sanofi

    • Concortis Biotherapeutics

    • Synthon Holding BV

    • Agensys

    By Type:

    • Adcetris

    • Kadcyla

    By End-User:

    • Breast Cancer

    • Lymphoma

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Antibody-drug Conjugate Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Antibody-drug Conjugate Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Antibody-drug Conjugate Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Antibody-drug Conjugate Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Antibody-drug Conjugate Market Analysis and Outlook to 2022

    • 7.1 Global Antibody-drug Conjugate Consumption (2017-2022)

    • 7.2 United States Antibody-drug Conjugate Consumption (2017-2022)

    • 7.3 Europe Antibody-drug Conjugate Consumption (2017-2022)

    • 7.4 China Antibody-drug Conjugate Consumption (2017-2022)

    • 7.5 Japan Antibody-drug Conjugate Consumption (2017-2022)

    • 7.6 India Antibody-drug Conjugate Consumption (2017-2022)

    • 7.7 South Korea Antibody-drug Conjugate Consumption (2017-2022)

    8 Region and Country-wise Antibody-drug Conjugate Market Analysis and Outlook to 2028

    • 8.1 Global Antibody-drug Conjugate Consumption Forecast (2022-2028)

    • 8.2 United States Antibody-drug Conjugate Consumption Forecast (2022-2028)

    • 8.3 Europe Antibody-drug Conjugate Consumption Forecast (2022-2028)

    • 8.4 China Antibody-drug Conjugate Consumption Forecast (2022-2028)

    • 8.5 Japan Antibody-drug Conjugate Consumption Forecast (2022-2028)

    • 8.6 India Antibody-drug Conjugate Consumption Forecast (2022-2028)

    • 8.7 South Korea Antibody-drug Conjugate Consumption Forecast (2022-2028)

    9 Global Antibody-drug Conjugate Market Outlook by Types and Applications to 2022

    • 9.1 Global Antibody-drug Conjugate Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Adcetris Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Kadcyla Consumption and Growth Rate (2017-2022)

    • 9.2 Global Antibody-drug Conjugate Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Breast Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Lymphoma Consumption and Growth Rate (2017-2022)

    10 Global Antibody-drug Conjugate Market Outlook by Types and Applications to 2028

    • 10.1 Global Antibody-drug Conjugate Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Adcetris Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Kadcyla Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Antibody-drug Conjugate Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Lymphoma Consumption Forecast and Growth Rate (2022-2028)

    11 Global Antibody-drug Conjugate Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Antibody-drug Conjugate Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Antibody-drug Conjugate Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Antibody-drug Conjugate Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Antibody-drug Conjugate Market Competitive Analysis

    • 14.1 Celldex Therapeutics

      • 14.1.1 Celldex Therapeutics Company Details

      • 14.1.2 Celldex Therapeutics Antibody-drug Conjugate Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Celldex Therapeutics Antibody-drug Conjugate Product and Service

    • 14.2 Sanofi

      • 14.2.1 Sanofi Company Details

      • 14.2.2 Sanofi Antibody-drug Conjugate Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Sanofi Antibody-drug Conjugate Product and Service

    • 14.3 Concortis Biotherapeutics

      • 14.3.1 Concortis Biotherapeutics Company Details

      • 14.3.2 Concortis Biotherapeutics Antibody-drug Conjugate Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Concortis Biotherapeutics Antibody-drug Conjugate Product and Service

    • 14.4 Synthon Holding BV

      • 14.4.1 Synthon Holding BV Company Details

      • 14.4.2 Synthon Holding BV Antibody-drug Conjugate Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Synthon Holding BV Antibody-drug Conjugate Product and Service

    • 14.5 Agensys

      • 14.5.1 Agensys Company Details

      • 14.5.2 Agensys Antibody-drug Conjugate Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Agensys Antibody-drug Conjugate Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Antibody-drug Conjugate

    • Figure Antibody-drug Conjugate Picture

    • Table Global Antibody-drug Conjugate Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Antibody-drug Conjugate Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Antibody-drug Conjugate Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Antibody-drug Conjugate Consumption by Country (2017-2022)

    • Figure United States Antibody-drug Conjugate Consumption and Growth Rate (2017-2022)

    • Table Europe Antibody-drug Conjugate Consumption and Growth Rate (2017-2022)

    • Figure China Antibody-drug Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Japan Antibody-drug Conjugate Consumption and Growth Rate (2017-2022)

    • Figure India Antibody-drug Conjugate Consumption and Growth Rate (2017-2022)

    • Figure South Korea Antibody-drug Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Global Antibody-drug Conjugate Consumption Forecast by Country (2022-2028)

    • Figure United States Antibody-drug Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Antibody-drug Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Antibody-drug Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Antibody-drug Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Antibody-drug Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Antibody-drug Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Adcetris Consumption and Growth Rate (2017-2022)

    • Figure Global Kadcyla Consumption and Growth Rate (2017-2022)

    • Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Lymphoma Consumption and Growth Rate (2017-2022)

    • Figure Global Adcetris Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Kadcyla Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lymphoma Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Antibody-drug Conjugate Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Antibody-drug Conjugate Export by Region (Top 5 Countries) (2017-2028)

    • Table Celldex Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Celldex Therapeutics Antibody-drug Conjugate Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celldex Therapeutics Antibody-drug Conjugate Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Antibody-drug Conjugate Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Antibody-drug Conjugate Product and Service

    • Table Concortis Biotherapeutics (Foundation Year, Company Profile and etc.)

    • Table Concortis Biotherapeutics Antibody-drug Conjugate Sales, Price, Value and Gross Profit (2017-2022)

    • Table Concortis Biotherapeutics Antibody-drug Conjugate Product and Service

    • Table Synthon Holding BV (Foundation Year, Company Profile and etc.)

    • Table Synthon Holding BV Antibody-drug Conjugate Sales, Price, Value and Gross Profit (2017-2022)

    • Table Synthon Holding BV Antibody-drug Conjugate Product and Service

    • Table Agensys (Foundation Year, Company Profile and etc.)

    • Table Agensys Antibody-drug Conjugate Sales, Price, Value and Gross Profit (2017-2022)

    • Table Agensys Antibody-drug Conjugate Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.